Zenas BioPharma, Inc. (ZBIO) stock
ZBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
$27.93−0.08 (-0.29%)
Close on Nov 16, 2026Market cap $1.82BP/E –Yield –
Zenas BioPharma enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Zenas BioPharma's enterprise value was $1.37B on Nov 11, 2026, against $1.41B a year earlier. Over the last 2 years it ranged from -$57.83M to $1.60B, with a median of $622.99M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.37B | +4.8% |
| 2025 | Dec 31, 2025 | $1.30B | – |
| 2024 | Dec 31, 2024 | -$44.61M | – |
See a number that looks wrong?